Heart valve development: endothelial cell signaling and differentiation.
暂无分享,去创建一个
[1] D. Rimm,et al. PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. , 1999, Journal of cell science.
[2] J. R. Zuberbuhler,et al. Prevalence of congenital cardiac anomalies at high altitude. , 1988, Journal of the American College of Cardiology.
[3] N. Copeland,et al. Erratum: Targeted disruption of the neurofibromatosis type 1 gene leads to developmental abnormalities of the heart and various neural crest-derived tissues (Genes and Development (1994) 8 (1019-1029)) , 1994 .
[4] L. Gavin,et al. Preconception care of diabetes. Glycemic control prevents congenital anomalies. , 1991, JAMA.
[5] Tak W. Mak,et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum , 1998, Nature.
[6] R. Markwald,et al. Genetic aspects of atrioventricular septal defects. , 2000, American journal of medical genetics.
[7] K. Miyazono,et al. Bone morphogenetic protein‐2 acts synergistically with transforming growth factor‐β3 during endothelial‐mesenchymal transformation in the developing chick heart , 1999, Journal of cellular physiology.
[8] R. Markwald,et al. Expression of smooth muscle alpha‐actin in mesenchymal cells during formation of avian endocardial cushion tissue: A role for transforming growth factor β3 , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.
[9] N. Copeland,et al. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. , 1994, Genes & development.
[10] Raymond B. Runyan,et al. Invasion of mesenchyme into three-dimensional collagen gels: a regional and temporal analysis of interaction in embryonic heart tissue. , 1983, Developmental biology.
[11] R R Markwald,et al. Molecular regulation of atrioventricular valvuloseptal morphogenesis. , 1995, Circulation research.
[12] G. Frantz,et al. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. , 1997, Development.
[13] J. McDonald,et al. Hyaluronan: Genetic insights into the complex biology of a simple polysaccharide , 2002, Glycoconjugate Journal.
[14] B. Hogan,et al. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). , 1990, Development.
[15] Michael J. Grusby,et al. The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.
[16] M. Lardelli,et al. Three novel Notch genes in zebrafish: implications for vertebrate Notch gene evolution and function , 1997, Development Genes and Evolution.
[17] R. Behringer,et al. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. J. Day,et al. Hyaluronan-binding Proteins: Tying Up the Giant* , 2002, The Journal of Biological Chemistry.
[19] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[20] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.
[21] P. Carmeliet,et al. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. , 2001, Development.
[22] 熊井 まどか. Loss of connexin45 causes a cushion defect in early cardiogenesis , 2000 .
[23] Gabriel Acevedo-Bolton,et al. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis , 2003, Nature.
[24] Rick B. Vega,et al. A Protein Encoded within the Down Syndrome Critical Region Is Enriched in Striated Muscles and Inhibits Calcineurin Signaling* , 2000, The Journal of Biological Chemistry.
[25] E. Carver,et al. The Mouse Snail Gene Encodes a Key Regulator of the Epithelial-Mesenchymal Transition , 2001, Molecular and Cellular Biology.
[26] Elazer R Edelman,et al. Tissue Engineering Therapy for Cardiovascular Disease , 2003, Circulation research.
[27] T. Magnuson,et al. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis , 2000, Nature Genetics.
[28] M. Nieto,et al. The snail superfamily of zinc-finger transcription factors , 2002, Nature Reviews Molecular Cell Biology.
[29] Raymond B. Runyan,et al. Slug is an essential target of TGFbeta2 signaling in the developing chicken heart. , 2000, Developmental biology.
[30] J. Epstein,et al. Molecular markers of cardiac endocardial cushion development , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.
[31] C. Ferencz. Epidemiology of congenital heart disease : The Baltimore-Washington Infant Study 1981-1989 , 1993 .
[32] R. Cripps,et al. Control of cardiac development by an evolutionarily conserved transcriptional network. , 2002, Developmental biology.
[33] J. Epstein,et al. Nf1 has an essential role in endothelial cells , 2003, Nature Genetics.
[34] E. Délot,et al. Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. , 2003, Molecular genetics and metabolism.
[35] G M Hutchins,et al. The development of the semilunar valves in the human heart. , 1974, The American journal of pathology.
[36] Michael A. Patton,et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome , 2001, Nature Genetics.
[37] T. Camenisch,et al. Elevated glucose inhibits VEGF-A–mediated endocardial cushion formation , 2003, The Journal of cell biology.
[38] Lin Chen,et al. Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.
[39] B. Hogan,et al. Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. , 1991, Development.
[40] S. Hokari,et al. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: Roles of transforming growth factor (TGF)‐β and bone morphogenetic protein (BMP) , 2000, The Anatomical record.
[41] K. Miyazono,et al. Induction of Smad6 mRNA by bone morphogenetic proteins. , 1998, Biochemical and biophysical research communications.
[42] M. Gimbrone,et al. A role for Smad6 in development and homeostasis of the cardiovascular system , 2000, Nature Genetics.
[43] J. Schmitt,et al. A Murine Model of Holt-Oram Syndrome Defines Roles of the T-Box Transcription Factor Tbx5 in Cardiogenesis and Disease , 2001, Cell.
[44] R. Markwald,et al. Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. , 2004, Developmental biology.
[45] A. Schier,et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. , 1996, Development.
[46] D G Wilkinson,et al. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. , 1994, Science.
[47] Katherine E Yutzey,et al. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. , 2004, Developmental biology.
[48] X. Estivill,et al. Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis , 2001, Mechanisms of Development.
[49] Margaret Robertson,et al. The neurofibromatosis type 1 gene encodes a protein related to GAP , 1990, Cell.
[50] Y. Dor,et al. VEGF modulates early heart valve formation. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[51] N. Copeland,et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. , 1994, Genes & development.
[52] A. Nagy,et al. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. , 2000, Development.
[53] S. Klewer,et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. , 2000, The Journal of clinical investigation.
[54] R. Markwald,et al. Extracellular matrix from embryonic myocardium elicits an early morphogenetic event in cardiac endothelial differentiation. , 1987, Developmental biology.
[55] M. Khoury,et al. Population-based study of congenital heart defects in Down syndrome. , 1998, American journal of medical genetics.
[56] J. Pérez-Pomares,et al. Immunolocalization of the transcription factor Slug in the developing avian heart , 2000, Anatomy and Embryology.
[57] R. Markwald,et al. Migratory behavior of cardiac cushion tissue cells in a collagen-lattice culture system. , 1982, Developmental biology.
[58] M. Klagsbrun,et al. Heparin-binding EGF-like growth factor. , 1997, Biochimica et biophysica acta.
[59] I. Zachary,et al. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. , 2001, Cardiovascular research.
[60] A. Moorman,et al. The development of the atrioventricular junction in the human heart. , 1996, Circulation research.
[61] K. Lyons,et al. BMP signaling is required for septation of the outflow tract of the mammalian heart , 2003, Development.
[62] D. Stainier,et al. UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. , 2001, Science.
[63] Rick B. Vega,et al. Multiple Domains of MCIP1 Contribute to Inhibition of Calcineurin Activity* , 2002, The Journal of Biological Chemistry.
[64] Frank McCormick,et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.
[65] K. Cunningham,et al. A conserved family of calcineurin regulators. , 2000, Genes & development.
[66] Katherine E Yutzey,et al. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.
[67] E. Olson,et al. Independent Signals Control Expression of the Calcineurin Inhibitory Proteins MCIP1 and MCIP2 in Striated Muscles , 2000, Circulation research.
[68] Arthur D. Lander,et al. The Elusive Functions of Proteoglycans , 2000, The Journal of cell biology.
[69] S. Artavanis-Tsakonas,et al. Notch signaling: cell fate control and signal integration in development. , 1999, Science.
[70] E. Cuppen,et al. The Wnt/beta-catenin pathway regulates cardiac valve formation. , 2003, Nature.
[71] David C. Lee,et al. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling , 2003, Journal of Molecular Medicine.
[72] J A Epstein,et al. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. , 1998, Development.
[73] M. Kirby,et al. Neural crest cells contribute to normal aorticopulmonary septation. , 1983, Science.
[74] N. W. Shworak,et al. Angiogenic modulators in valve development and disease: does valvular disease recapitulate developmental signaling pathways? , 2004, Current opinion in cardiology.
[75] R. Kim,et al. Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. , 2001, Developmental biology.
[76] Rüdiger Klein,et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor , 1995, Nature.
[77] J. Rossant,et al. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. , 1999, Developmental biology.
[78] G. Crabtree,et al. NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.
[79] J. Massagué,et al. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.
[80] Lilly Y. W. Bourguignon,et al. Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.
[81] F. Schoen,et al. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. , 2001, The American journal of pathology.
[82] E. Olson,et al. Heart development: learning from mistakes. , 2002, Current opinion in genetics & development.
[83] Robert H. Anderson,et al. Development of the heart: (2) Septation of the atriums and ventricles , 2003, Heart.
[84] S. Klewer,et al. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors , 2002, Nature Medicine.
[85] C. Romano,et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. , 2000, American journal of medical genetics.
[86] M. Goumans,et al. Differential expression of BMP receptors in early mouse development. , 1997, The International journal of developmental biology.
[87] L. Zon,et al. Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects , 2003, Mechanisms of Development.
[88] David C. Lee,et al. Defective valvulogenesis in HB‐EGF and TACE‐null mice is associated with aberrant BMP signaling , 2003, The EMBO journal.
[89] E. Robert. Epidemiology of congenital heart disease: The Baltimore-Washington Infant Study, 1981–1989 (Perspectives in Pediatric cardiology series, volume 4) , 1994 .
[90] A. Nagy,et al. Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. , 2001, The American journal of pathology.
[91] K. Willecke,et al. Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system. , 1997, Circulation research.
[92] Elaine Fuchs,et al. Sticky Business Orchestrating Cellular Signals at Adherens Junctions , 2003, Cell.
[93] K. Yutzey,et al. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice. , 2004, Developmental biology.
[94] M Tammi,et al. Hyaluronan synthases. , 1997, The Journal of biological chemistry.
[95] R. Markwald,et al. Structural development of endocardial cushions. , 1977, The American journal of anatomy.
[96] A. Lassar,et al. Inhibition of Wnt activity induces heart formation from posterior mesoderm. , 2001, Genes & development.
[97] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[98] F. Schoen,et al. NFATc1 Mediates Vascular Endothelial Growth Factor-induced Proliferation of Human Pulmonary Valve Endothelial Cells* , 2003, The Journal of Biological Chemistry.
[99] C. Loffredo. Epidemiology of cardiovascular malformations: prevalence and risk factors. , 2000, American journal of medical genetics.
[100] F. Schoen,et al. Aortic Valve Endothelial Cells Undergo Transforming Growth Factor-β-Mediated and Non-Transforming Growth Factor-β-Mediated Transdifferentiation in Vitro , 2001 .
[101] R. McCarter,et al. Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. , 1990, Teratology.